Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline Full Text
Annals of Internal Medicine,  Evidence Based Medicine  Clinical Article

Fink HA et al. – The role of chronic kidney disease (CKD) screening or monitoring in improving clinical outcomes is uncertain. Evidence for CKD treatment benefit is strongest for angiotensin–converting enzyme inhibitors and angiotensin II–receptor blockers, and in patients with albuminuria combined with diabetes or cardiovascular disease.

Methods
  • MEDLINE (1985 through November 2011), reference lists, and expert suggestions.
  • English–language, randomized, controlled trials that evaluated screening for or monitoring or treatment of CKD and that reported clinical outcomes.
  • Two reviewers assessed study characteristics and rated quality and strength of evidence.
  • No trials evaluated screening or monitoring, and 110 evaluated treatments.

Results
  • Angiotensin–converting enzyme inhibitors (relative risk, 0.65 [95% CI, 0.49 to 0.88]) and angiotensin II–receptor blockers (relative risk, 0.77 [CI, 0.66 to 0.90]) reduced end–stage renal disease versus placebo, primarily in patients with diabetes who have macroalbuminuria.
  • Angiotensin–converting enzyme inhibitors reduced mortality versus placebo (relative risk, 0.79 [CI, 0.66 to 0.96]) in patients with microalbuminuria and cardiovascular disease or high–risk diabetes.
  • Statins and β–blockers reduced mortality and cardiovascular events versus placebo or control in patients with impaired estimated glomerular filtration rate and either hyperlipidemia or congestive heart failure, respectively.
  • Risks for mortality, end–stage renal disease, or other clinical outcomes did not significantly differ between strict and usual blood pressure control.
  • The strength of evidence was rated high for angiotensin II–receptor blockers and statins, moderate for angiotensin–converting enzyme inhibitors and β–blockers, and low for strict blood pressure control.

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Nephrology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nephrology Articles

1 Metformin in chronic kidney disease: Time for a rethink Peritoneal Dialysis International, July 9, 2014    Clinical Article

2 Associations of sugar and artificially sweetened soda and chronic kidney disease: A systematic review and meta-analysis Nephrology, September 26, 2014    Evidence Based Medicine    Review Article

3 Tonsillectomy for IgA nephropathy: A meta-analysis American Journal of Kidney Diseases, October 29, 2014    Evidence Based Medicine

4 Effects of tea intake on blood pressure: A meta-analysis of 21 randomized controlled trials JACC - Journal of the American College of Cardiology, October 22, 2014    Clinical Article

5 High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: The chronic renal insufficiency cohort (CRIC) study Journal of the American Society of Nephrology, October 8, 2014    Clinical Article

6 Medications associated with restless legs syndrome: a case–control study in the US Renal Data System (USRDS) Sleep Medicine, October 8, 2014    Clinical Article

7 Erythropoietin administration for prevention of cardiac surgery-associated acute kidney injury: A meta-analysis of randomized controlled trials European Journal of Cardio-Thoracic Surgery, October 24, 2014    Evidence Based Medicine    Review Article

8 ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010 American Journal of Kidney Diseases, August 18, 2014    Clinical Article

9 Association of higher erythropoiesis stimulating agent dose and mortality in children on dialysis Pediatric Nephrology, September 25, 2014    Clinical Article

10 Randomized, double-blind, placebo-controlled trial of spironolactone for hypokalemia in continuous ambulatory peritoneal dialysis patients Therapeutic Apheresis and Dialysis, September 15, 2014    Clinical Article

11 Daily protein intake and patient outcomes in severe acute kidney injury: Findings of the randomized evaluation of normal versus augmented level of replacement therapy (RENAL) trial Blood Purification, September 4, 2014    Clinical Article

12 Heparin use in hemodialysis patients following gastrointestinal bleeding American Journal of Nephrology, October 20, 2014    Clinical Article

13 A meta-analysis of stent placement vs. angioplasty for dialysis vascular access stenosis Seminars in Dialysis, October 13, 2014    Evidence Based Medicine    Clinical Article

14 Erythropoiesis-stimulating agents (ESA) for preventing the progression of chronic kidney disease: A meta-analysis of 19 studies American Journal of Nephrology, October 15, 2014    Evidence Based Medicine    Review Article

15 Rituximab treatment for fibrillary glomerulonephritis Nephrology Dialysis Transplantation, October 1, 2014    Clinical Article

16 The changing landscape of home dialysis in the United States Current Opinion in Nephrology and Hypertension, October 14, 2014    Review Article

17 Body mass index and mortality in kidney transplant recipients: A systematic review and meta-analysis American Journal of Nephrology, October 21, 2014    Evidence Based Medicine    Review Article

18 The role of statins in preventing contrast-induced acute kidney injury: a narrative review Angiology, September 17, 2014    Review Article    Clinical Article

19 Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors Clinical Journal of the American Society of Nephrology, October 17, 2014    Clinical Article

20 The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis QJM: An International Journal of Medicine, October 2, 2014    Evidence Based Medicine    Review Article
Exclusive Author Commentary

Indexed Journals in Nephrology: Kidney International, Hemodialysis International, Nephrology Dialysis Transplantationmore